VOR
Vor Biopharma Inc
19.10$
+4.1%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -57.3% | +5.7% | -4.6% | +0.0% | -3.9% | -4.6% | +154.5% | – | – | +21.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -24.3% | +16.4% | -10.3% | 0.0% | +16.2% | +5.3% | +879.4% | -94.6% | +35.7% | -8.3% | +47.3% | – | |
| – | -6.3% | +10.8% | -9.9% | -7.2% | -10.9% | +10.5% | -63.6% | +501.4% | +16.3% | +4.6% | +25.1% | – | |
| – | -22.9% | +15.2% | -10.3% | +1.3% | +6.8% | +9.3% | +723.9% | -89.8% | +27.9% | -2.3% | +36.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -112.7% | – | – | |
| – | -60.3% | +59.2% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -112.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -112.7% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.